This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
HanchorBio Inc.
HanchorBio Inc., a leading biotechnology firm headquartered in Taiwan (TW), has been at the forefront of innovative solutions since its establishment. Specialising in advanced biopharmaceuticals and cutting-edge research, the company operates primarily in the Asia-Pacific region, with a growing presence in global markets. Founded in 2015, HanchorBio has achieved significant milestones, including the development of unique therapeutic products that address unmet medical needs. Their core offerings, which include monoclonal antibodies and biologics, are distinguished by their precision and efficacy, setting new standards in the industry. With a strong commitment to research and development, HanchorBio has positioned itself as a key player in the biopharmaceutical landscape, recognised for its contributions to healthcare advancements and patient outcomes.
DitchCarbon Score
How does HanchorBio Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HanchorBio Inc.'s score of 17 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HanchorBio Inc.'s reported carbon emissions
In 2024, HanchorBio Inc., headquartered in Taiwan (TW), reported total carbon emissions of approximately 54,110,000 kg CO2e. This figure includes 2,966,000 kg CO2e from Scope 1 emissions, 340,000 kg CO2e from Scope 2 emissions, and a significant 50,804,000 kg CO2e from Scope 3 emissions. Despite the substantial emissions, there are currently no publicly disclosed reduction targets or climate pledges from HanchorBio Inc. This lack of specific commitments may reflect a broader industry context where many companies are still developing their climate strategies. HanchorBio Inc. does not inherit emissions data from any parent company, indicating that its reported figures are solely its own. The company has not yet established any Science-Based Targets Initiative (SBTi) reduction targets or other formal climate initiatives. As the company continues to navigate its environmental impact, stakeholders may look for future commitments to reduce emissions and enhance sustainability practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HanchorBio Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
